Paula Vainio


Clinical Lecturer, Institute of Biomedicine (Institute of Biomedicine)

pajogr@utu.fi
+358 29 450 4527
+358 50 322 4370

Kiinamyllynkatu 10
Turku





Publications

IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy (2019)
Journal of Magnetic Resonance Imaging
Merisaari H., Jambor I., Ettala O., Boström P.J., Montoya Perez I., Verho J., Kiviniemi A., Syvänen K., Kähkönen E., Eklund L., Pahikkala T., Vainio P., Saunavaara J., Aronen H.J., Taimen P.
(
A1 Journal article – refereed)

Novel COL1A1 Mutation c.3290G > T Associated With Severe Form of Osteogenesis Imperfecta in a Fetus (2017)
Pediatric and Developmental Pathology
Tanner L, Vainio P, Sandell M, Laine J
(
A1 Journal article – refereed)

PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells (2017)
Journal of Pathology: Clinical Research
Lehtinen Laura, Vainio Paula, Wikman Harriet, Huhtala Heini, Mueller Volkmar, Kallioniemi Anne, Pantel Klaus, Kronqvist Pauliina, Kallioniemi Olli, Carpen Olli, Iljin Kristiina
(
A1 Journal article – refereed)

Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method (2016) Ginsburg SB, Taimen P, Merisaari H, Vainio P, Boström PJ, Aronen HJ, Jambor I, Madabhushi A
(
A1 Journal article – refereed)

High-throughout transriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer (2012)
PLoS ONE
Paula Vainio, John-Patrick Mpindi, Pekka Korhonen, Vidal Fey, Tuomas Mirtti, Kalle A Alanen, Merja Perälä, Olli Kallioniemi, Kristiina Iljin
(
A1 Journal article – refereed)

Integrative genomic, transcriptomic, and RNAi analysis indicates a potential oncogenic role for FAM110B in castration-resistant prostate cancer (2012)
Prostate
Vainio Paula, Wolf Maija, Edgren Henrik, He Tao, Kohonen Pekka, Mpindi John-Patrick, Smit Frank, Verhaegh Gerald, Schalken Jack, Perälä Merja, Iljin Kristiina, Kallioniemi Olli
(
A1 Journal article – refereed)

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer (2011)
American Journal of Pathology
Vainio Paula, Gupta Santosh, Ketola Kirsi, Mirtti Tuomas, Mpindi John-Patrik, Kohonen Pekka, Fey Vidal, Perälä Merja, Smit Frank, Verhaegh Gerald, Schalken Jack, Alanen Kalle A, Kallioniemi Olli, Iljin Kristiina
(
A1 Journal article – refereed)

GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets (2011)
PLoS ONE
Mpindi JP, SARA H, Haapa-Paananen S, Kilpinen S, Pisto T, BUCHER E, OJALA K, Iljin K, VAINIO P, BJORKMAN M, GUPTA S, Kohonen P, NEES M, KALLIONIEMI O
(
A1 Journal article – refereed)

Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins (2011)
Oncotarget
Vainio Paula, Lehtinen Laura, Mirtti Tuomas, Hilvo Mika, Seppänen-Laakso Tuulikki, Virtanen Johannes, Sankila Anna, Nordling Stig, Lundin Johan, Rannikko Antti, Orešic Matej, Kallioniemi Olli, Iljin Kristiina
(
A1 Journal article – refereed)

FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells (2010)
Cancer Research
Gupta S, Iljin K, Sara H, Mpindi JP, Mirtti T, Vainio P, Rantala J, Alanen K, Nees M, Kallioniemi O
(
A1 Journal article – refereed)


Last updated on 2019-19-07 at 02:20